Abstract

The project is to evaluate chronic toxicity and safety in middle‐aged ovariectomized rats supplemented with different dosages of green tea polyphenols (GTP) in drinking water. 182 SD were sham (n=39) or ovariectomized (OVX, n=143). Both sham and OVX‐control animals receiving no GTP were assigned for sample collection at baseline, 3, and 6 months. The remaining OVX animals were randomized into 0.15%, 0.5%, 1%, and 1.5% (wt/vol) GTP for 3 and 6 months. Routinely clinical observation was performed. Ophthalmologic examination (control, 1% and 1.5% GTP groups), blood for hematology and clinical chemistry, urine analysis were assessed at baseline, 3, and 6 months. Histologic examination was performed on all tissues from animals in both control and high dose groups at baseline and the end of study. No mortality or abnormal treatment‐related findings in clinical observations or ophthalmologic examinations were noted. No treatment‐related macroscopic or microscopic findings were noted for animals administered 1.5% GTP. There was no difference in baseline body weight among all OVX‐treated treatment groups. The OVX+1.5% GTP group had the smallest body weight of the OVX‐treated groups. No difference in food intake among all treatment groups. In all OVX‐treated groups, GTP supplementation decreased water consumption of rats in a dose‐dependent pattern. At 6 months, GTP intake did not affect complete hematology, clinical chemistry, and urinalysis, except for PO4 and BUN (increased); total cholesterol, BUN, LDH, and urine pH (decreased).This study reveals that the No‐Observed‐Effect Level (NOEL) of GTP is 1.5%, the highest dose used. Supported by NIH/NCCAM AT006691.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.